Form 4: Skye Bioscience Insider Sells Shares
Insider Transaction (Form 4)
5AM Partners VII, LLC and 7 others reported changes in beneficial ownership of Skye Bioscience, Inc. common stock on August 18, 2026.
Summary
- Open-market sale: disposed of 45,090 Common Stock at $0.38 ($17,134) on August 18, 2026; holds 1,411,974 after (Indirect).
- Open-market sale: disposed of 1,830 Common Stock at $0.38 ($695) on August 18, 2026; holds 55,663 after (Indirect).
- Open-market sale: disposed of 253,080 Common Stock at $0.38 ($96,170) on August 18, 2026; holds 7,914,126 after (Indirect).
- Open-market sale: disposed of 10,255 Common Stock at $0.35 ($3,589) on August 19, 2026; holds 1,401,719 after (Indirect).
- Open-market sale: disposed of 409 Common Stock at $0.35 ($143) on August 19, 2026; holds 55,254 after (Indirect).
- Open-market sale: disposed of 57,476 Common Stock at $0.35 ($20,117) on August 19, 2026; holds 7,856,650 after (Indirect).
- Open-market sale: disposed of 1,159 Common Stock at $0.32 ($371) on August 20, 2026; holds 1,400,560 after (Indirect).
- Open-market sale: disposed of 46 Common Stock at $0.32 ($15) on August 20, 2026; holds 55,208 after (Indirect).
- Open-market sale: disposed of 6,495 Common Stock at $0.32 ($2,078) on August 20, 2026; holds 7,850,155 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $140,313 of stock on the open market.
Insider Transactions
5AM Partners VII, LLC — 10% owner
5AM Ventures VII, L.P. — 10% owner
5AM Partners II, LLC — 10% owner
5AM Ventures II LP — 10% owner
5Am Co-Investors Ii Lp — 10% owner
John D Diekman — 10% owner
Kush Parmar — 10% owner
Scott M Rocklage — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 45,090 | $0 | $17.1K | 1,411,974 |
| 2026-08-18 | Open-market sale | Common Stock | 1,830 | $0 | $695 | 55,663 |
| 2026-08-18 | Open-market sale | Common Stock | 253,080 | $0 | $96.2K | 7,914,126 |
| 2026-08-19 | Open-market sale | Common Stock | 10,255 | $0 | $3.6K | 1,401,719 |
| 2026-08-19 | Open-market sale | Common Stock | 409 | $0 | $143 | 55,254 |
| 2026-08-19 | Open-market sale | Common Stock | 57,476 | $0 | $20.1K | 7,856,650 |
| 2026-08-20 | Open-market sale | Common Stock | 1,159 | $0 | $371 | 1,400,560 |
| 2026-08-20 | Open-market sale | Common Stock | 46 | $0 | $15 | 55,208 |
| 2026-08-20 | Open-market sale | Common Stock | 6,495 | $0 | $2.1K | 7,850,155 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (45,090 shares) |
| 2026-08-18 | Open-market sale (1,830 shares) |
| 2026-08-18 | Open-market sale (253,080 shares) |
| 2026-08-19 | Open-market sale (10,255 shares) |
| 2026-08-19 | Open-market sale (409 shares) |
| 2026-08-19 | Open-market sale (57,476 shares) |
| 2026-08-20 | Open-market sale (1,159 shares) |
| 2026-08-20 | Open-market sale (46 shares) |
| 2026-08-20 | Open-market sale (6,495 shares) |
Keywords
insider transaction, Form 4, SKYE, Skye Bioscience, Inc., bearish, 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5Am Co-Investors Ii Lp, John D Diekman, Kush Parmar, Scott M Rocklage
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.